Health care stocks fell Thursday afternoon, with the NYSE Health Care Index easing 0.1% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.3%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, NRX Pharmaceuticals (NRXP) shares surged 38%. The Hope Therapeutics unit plans to acquire the Kadima Neuropsychiatry Institute.
Avalo Therapeutics (AVTX) shares jumped 14. Jennifer Riley was appointed to the newly created role of chief strategy officer.
Neumora Therapeutics (NMRA) shares plunged 82% after a phase 3 trial of navacaprant to treat major depressive disorder failed to meet the primary endpoint.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments